Dow climbs 228 points on positive vaccine data, big Goldman earnings beat

Business Insider

Published

· *US stocks rose on Wednesday after the drugmaker Moderna announced that all participants in an early trial of its coronavirus vaccine candidate developed antibodies.*
· *Major indexes were also lifted by strong quarterly earnings from Goldman Sachs that handily beat analysts' profit estimates.*
· *The so-called reopening...

Full Article